Orsolya Rideg
Overview
Explore the profile of Orsolya Rideg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rideg O, Dergez T, Farkas K, Kovacs K, Kalman E, Tornoczky T, et al.
Vaccines (Basel)
. 2022 May;
10(5).
PMID: 35632504
Identification of HPV infection is usually performed on cytological specimens, despite the often transient virus types. HPV profile analysis of pathologically confirmed lesions can also be performed on formalin-fixed paraffin-embedded...
2.
Rideg O, Oszter A, Makk E, Kalman E, Farkas K, Tornoczky T, et al.
Vaccines (Basel)
. 2021 Jul;
9(6).
PMID: 34198774
External anogenital warts (EGW) are primarily associated with the low-risk human papillomavirus (HPV) genotypes 6 and 11, though coinfection with other low-risk and oncogenic high-risk HPV genotypes also occurs. Although...
3.
Tokes-Fuzesi M, Ruzsics I, Rideg O, Kustan P, Kovacs G, Molnar T
Int J Chron Obstruct Pulmon Dis
. 2018 Dec;
13:3749-3757.
PMID: 30532530
Background: Microparticles (MPs) are shedding membrane vesicles released from activated blood and endothelial cells under inflammatory conditions. The role of endothelial MPs (EMPs) in pathophysiology of COPD is relatively well...
4.
Labadi A, Grassi E, Gellen B, Kleinau G, Biebermann H, Ruzsa B, et al.
J Clin Endocrinol Metab
. 2015 May;
100(7):E1039-45.
PMID: 25978107
Context: Congenital hypothyroidism (CH) is one of the most common inborn endocrine disorders with genetic background. Despite the well-established newborn CH screening program in Hungary, no systematic examination of the...
5.
Aradi D, Rideg O, Vorobcsuk A, Magyarlaki T, Magyari B, Konyi A, et al.
Eur J Clin Invest
. 2011 Sep;
42(4):384-92.
PMID: 21902692
Background: The GRAVITAS trial showed that 150 mg clopidogrel did not improve outcome in patients with high on-clopidogrel platelet reactivity (HPR) screened by the VerifyNow assay. We aimed to determine...
6.
Rideg O, Haber A, Botz L, Szucs F, Varnai R, Miseta A, et al.
Cell Biochem Funct
. 2011 Aug;
29(7):562-8.
PMID: 21826689
Polymorphisms of CYP450 metabolizer enzymes and transport proteins play crucial roles in the inter-individual variability of drug efficiency. The aim of our study was to predict the frequency of functional...
7.
Rideg O, Komocsi A, Magyarlaki T, Tokes-Fuzesi M, Miseta A, Kovacs G, et al.
Pharmacogenomics
. 2011 Aug;
12(9):1269-80.
PMID: 21806387
Aim: To determine the effect of various SNPs on post-clopidogrel platelet reactivity and clinical outcome. Materials & Methods: Cytochrome 2C19 (CYP2C19) loss-of-function (LOF; *2, *3) and gain-of-function (GOF; *17) allelic...
8.
Aradi D, Komocsi A, Vorobcsuk A, Rideg O, Tokes-Fuzesi M, Magyarlaki T, et al.
Am Heart J
. 2010 Sep;
160(3):543-51.
PMID: 20826265
Background: A growing number of observational studies suggest that high on-clopidogrel platelet reactivity (HPR) is associated with recurrent thrombotic events after percutaneous coronary intervention. We aimed to perform an updated...
9.
Aradi D, Magyarlaki T, Tokes-Fuzesi M, Rideg O, Vorobcsuk A, Komocsi A
Platelets
. 2010 Jul;
21(7):563-70.
PMID: 20642320
No consensus exists regarding the optimal estimate of light transmission aggregometry (LTA) to reflect P2Y12 ADP receptor inhibition in patients receiving thienopyridine therapy. Currently, the only completely P2Y12-receptor specific method...
10.
Nagy T, Balasa A, Frank D, Rab A, Rideg O, Kotek G, et al.
Eur Biophys J
. 2010 Jan;
39(8):1207-17.
PMID: 20043149
An increasing amount of recent research has demonstrated that the hexosamine biosynthesis pathway (HBP) plays a significant role in the modulation of intracellular signaling transduction pathways, and affects cellular processes...